FDA to review data in real time, SCOTUS hears ‘skinny label’ case
Top of the morning to you. The middle of the week is upon us and, since you made…
Delhi to boost homoeopathy, integrate AYUSH with mainstream healthcare: Minister
New Delhi, The Delhi government is working to strengthen homoeopathy services and integrate AYUSH systems with mainstream healthcare,…
18-month warning for anyone coming off Ozempic or Wegovy
‘Doctors and patients should be aware.’ People using GLP-1 drugs like Ozempic, Wegovy and others for weight loss…
Data reveals 73 per cent of NICE-approved medicines prescribed more often
In News Follow this topic Bookmark Record learning outcomes Three in four medicines approved by the National Institute…
South Fulton hosts prescription drug take back event
ATLANTA, Ga. (Atlanta News First) — The City of South Fulton, along with Fulton County, are working to…
Modern Morals: My friend has become extremely thin using weight-loss drugs – I’m really worried about her
When I voiced my concerns, she said she had reduced her dose, but she’s lost more weight since.…
Study Reveals Unknown GLP-1 Side Effects Reported on Reddit
Published April 30, 2026 02:45PM Key Takeaways: A recent study published in Nature Health used AI to analyze 400,000…
The struggle to get hold of medication in England is set to get worse
Medicine prices are rising because it is becoming more expensive and more difficult for manufacturers and suppliers to…
Medford hosting free prescription drug take-back event May 2 | Local
MEDFORD, Ore. – The city is hosting a free Drug Take Back Event and Rogue Shred Event on…
What’s the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
Investors are always on the lookout for the next revolutionary technology or product. In recent times, this has…
Protect patient access to life-saving drugs | GUEST COLUMN
By Leslie Herod Since its inception, Colorado’s Prescription Drug Affordability Board (PDAB) created fear among patients around effects…
FDA proposes excluding Novo, Lilly GLP-1s from compounding list
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…